Single Station N2 NSCLC: A Brief Reflection on Possible Overdoing

Annals of Thoracic Surgery

Volumn 88, Issue 6, 2009, Pages 2069-2070

  Cafarotti, Stefano ^a   Cesario, Alfredo ^a,b   Cusumano, Giacomo ^a   Granone, Pierluigi ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AORTOPULMONARY SEPTAL DEFECT; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER; HUMAN; INTERMETHOD COMPARISON; LETTER; LIGAMENT; LUNG NON SMALL CELL CANCER; LYMPH NODE; MEDIASTINUM LYMPH NODE; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MEDIASTINAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 71649105574     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.06.104     Document Type: Letter

References (7)

1. Misthos P., Sepsas E., Kokotsakis J., Skottis I., and Lioulias A. The significance of one-station N2 disease in the prognosis of patients with non small-cell lung cancer. Ann Thorac Surg 86 (2008) 1626-1631
2. Detterbeck F. Invited commentary. Ann Thorac Surg 86 (2008) 1631
3. Andrè F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., and Brichon P.Y. Survival of patients with resected N2 non small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18 (2000) 2981-2989
4. Albain K.S., Swann R.S., Rusch V.R., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup (2005), ASCO, Orlando, FL
5. van Meerbeeck J.P., Kramer G., van Schil P.E., et al. A randomized trial of radical surgery versus thoracic radiotherapy in patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (2005), ASCO, Orlando, FL
6. Martini N., and Flehinger B.J. The role of surgery I N2 lung cancer. Surg Clin North Am 67 (1987) 1037-1049
7. Ohta Y., Shimizu Y., Minato H., Matsumoto I., Oda M., and Watanabe G. Results of initial operations in non-small cell lung cancer patients with single level n2 disease. Ann Thorac Surg 81 (2006) 427-433